Authors


Robert Brunault, PharmD

Latest:

Case Studies (July 2015)

What should these pharmacists do?


Catherine Defino, PharmD, RPh

Latest:

Atezolizumab and Nab-Paclitaxel for the Treatment of Triple-Negative Breast Cancer

Compared with other breast cancer subtypes, TNBC is more likely to be diagnosed in younger women and is more likely to have metastases present at the time of diagnosis.



Dan Pollard, PhD, MBA

Latest:

A Pharmacy on Every Corner or Prescription Drug Costs on Every Phone?

Changes in purchasing behavior have immediate and long-term effects on health care costs for both individuals and employers.


Kelly Ratliff, President, US Bioservices

Latest:

Achieve Gold Standard Oral Oncology Drug Adherence Through Collaboration

Health care providers—including physicians, oncologists, and specialty pharmacists—must leverage their collective resources and expertise to work together to address adherence on a larger scale. 


Robert Hiscock, MA

Latest:

Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic Therapies

Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.



Tanmayi Gupta, PharmD, Clinical Manager of Quality

Latest:

Patient-Centered Multidisciplinary Care Key to Value-based Care

2019 Pharmacy Quality Alliance Annual Meeting included discussions on measures to improve medication services and how pharmacists can play a larger role in the multidisciplinary care team.


Ashley Mains Espinosa, PharmD, MS, CPHIMS, FASHP

Latest:

Partner With 340B Executive Stakeholders

At minimum, they should engage in compliance risks; financial opportunities; key advocacy efforts; and program resources, structure, and value.


Daniel Holland, PharmD

Latest:

What Patients On a Vegan Diet Need to Know About Medications

Animal products are prevalent in pharmaceuticals manufacturing, including in some unexpected places.


Anna Kaltenboeck, MA

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.



Raven Jackson, PharmD, Candace Hopgood, PharmD, Vy Nguyen, PharmD

Latest:

How Will Pharmacists Practice in 2015: A 2017 Response

Pharmacists must continue to evolve to the needs of their patients and always remain a key player in health care decisions.


Keith Hasson

Latest:

Fraud Cases Underscore New Challenges for Compounding Pharmacies

Compounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.


Debra A. Bowers, BA

Latest:

Comparison of Pharmacists and Primary Care Providers as Immunizers

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.



Anne Marie (Sesti) Kondic, PharmD

Latest:

Look and Look Again -- Getting to Know the Community Pharmacy Foundation

Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.



Melinda J. Throm, PharmD, BCPS

Latest:

Continuity of Care: Diabetic Neuropathy: Bridging the Sensation Gap

Pharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.


Douglas C. Higgins, RPh, FIACP

Latest:

USP Chapter : Nonsterile Compounding Pharmacy Air Flow Considerations

USP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.



David Hughes, PharmD, BCOP

Latest:

A New Monoclonal Antibody for R/R MM: Isatuximab-irfc

Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.


Gregory Burger, MS, RPh, FASHP

Latest:

Drug Diversion: New Approaches to an Old Problem

Drug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.



Royce Burruss, RPh, MBA, FASCP

Latest:

The Changing Clinical Assessment: An Overview and Next-Level Challenges

The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.




Mischa Pesicek, PharmD

Latest:

Walmart Essay Winner: A Community Pharmacist's Impact Can Go a Long Way

"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."